versión imprimible
 
 

Tumor Myeloid Microenvironment Directed Therapeutics Summit 2021

Evvnt Promotion / evvnt
-
16.03.2021 - 18.03.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Temas de la conferencia
With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47.

Tumor Myeloid Microenvironment Directed Therapeutics Summit is focused on optimizing the potential of immunotherapy, through direct modulation of tumor-resident myeloid populations to retune the microenvironment for improved response rates to therapy.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/701752-3?pid=4832

Speakers: Peter Ellmark, Alligator Bioscience AB, Victoria Smith, Amphivena Therapeutics Inc., Kaiming Ye, Binghamton University, Michael Klichinsky, Carisma Therapeutics and more
 

Información e inscripción:

https://go.evvnt.com/701752-0?pid=4832
Ms. Aarti Diwan
 
Categorías
Medicina General, Servicios de salud
Idioma
Inglés
Cuota del Congreso
USD 1499.00 - USD 2997.00
Los participantes esperaban
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinSwiss Tropical and Public Health InstituteAMREF - African Medical and Research FoundationCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAlumni Club Medizinische Universität WienHilfswerk AustriaÄrzte der WeltÄrztekammer für Wien